HELP Helus Pharma Inc. IFRS Annual reports only
Pharmaceutical Preparations · Nasdaq · SEC CIK 1833141 · Reporting currency CAD · Fiscal year ends 03/31
Financial factors as of 2025-03-31 (FY2025), by fiscal year; growth vs the previous fiscal year
Growth
Margins
Returns
Leverage & solvency
Cash quality & payout
Factor history charts and full statement history on Pro 🔒
Financial statements
| Unit: CAD | FY2025*2025-03-31 | FY2024*2024-03-31 |
|---|---|---|
| Income statement | ||
| Revenue | — | — |
| R&D expense | 54.91M | 32.36M |
| SG&A expense | 45.37M | 32.59M |
| Income tax | 0 | 0 |
| Net income | -113.14M | -78.08M |
| EPS (basic) | -5.59 | -9.41 |
| EPS (diluted) | — | — |
| Balance sheet | ||
| Cash & equivalents | 135.02M | 208.99M |
| Receivables | 5.88M | 4.48M |
| Current assets | 165.97M | 218.54M |
| PP&E, netmay include right-of-use assets (IFRS) | 141,000 | 266,000 |
| Goodwill | 51.49M | 47.48M |
| Intangibles | 41.02M | 35.47M |
| Total assets | 258.62M | 302.02M |
| Current liabilities | 21.42M | 10.10M |
| Total liabilities | 21.42M | 10.10M |
| Shareholders' equity | 237.20M | 291.93M |
| Cash flow statement | ||
| Operating cash flow | -101.30M | -68.91M |
| Capital expenditure | — | 21,000 |
| Free cash flow | — | -68.93M |
| Investing cash flow | -1.97M | 6.92M |
| Financing cash flow | 20.20M | 254.51M |
| Depreciation & amortization | 475,000 | 424,000 |
| Stock-based compensation | 42.87M | 13.89M |
Free plan shows the latest 2 periods; Pro shows all 5 🔒
· This company reports under IFRS: some line items differ from US GAAP — operating income is not required, interest expense may be broader "finance costs", and banks have no standard revenue line.
· This company files only annual reports with the SEC (20-F for foreign issuers), so there is no quarterly data; factors are by fiscal year and growth is vs the previous fiscal year.
· This company does not report gross profit in XBRL.
· This company reports EPS only by share class (e.g. class A/B), so it is shown as —.
· Amounts are in the company's reporting currency, CAD, not USD; the site does no currency conversion.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.